Maleate isomerase gene

Abstract

The present invention provides a gene coding for maleate isomerase excellent in stability, a recombinant vector having the gene, and a transformant transformed with the recombinant vector. According to the present invention, maleate isomerase excellent in stability can be produced efficiently in a large amount.

Description

FIELD OF THE INVENTION

The present invention relates to a gene coding for maleate isomerase, recombinant DNA containing the gene, a transformant carrying the recombinant DNA and a process for producing maleate isomerase by use of the transformant.

BACKGROUND OF THE INVENTION

Microorganisms belonging to the genera Alcaligenes, Pseudomonas, Achromobacter, Aerobacter, Bacillus and Brevibacterium are known as microorganisms producing L-aspartic acid from maleic acid and ammonia, and some of them have already been applied for patents (Japanese Patent Publication Nos. 2793/1963, 11993/1967, 11994/1967, and 8710/1968).

Two kinds of enzyme, that is, maleate isomerase and aspartase, are involved in conversion of ammonium maleate into L-aspartic acid, where aspartase is relatively stable, while maleate isomerase is unstable and its activity is inherently liable to reduction in particular by oxygen.

Further, the stability of this maleate isomerase varies depending on the strain, and if the microorganism is immobilized for use, the half-life of the activity is short and satisfactory production is not attained under the present circumstances.

SUMMARY OF THE INVENTION

The object of the present invention is to provide a gene for maleate isomerase excellent in stability, a recombinant vector containing the gene, and a transformant transformed with the recombinant DNA.

That is, the present invention relates to DNA encoding a protein of (a) or (b) follows:

(a) a protein whose amino acid sequence is represented by SEQ ID NO:1 or 2; and (b) a protein derived from the protein of (a) by substitution, deletion or addition of amino acid in the amino acid sequence defined in (a) and having maleate isomerase activity.

As a specific example of the DNA, mention is made of e.g. DNAs shown in SEQ ID NOS:3 and4. Deleted, substituted or added amino acids in (b) above refer preferably to one or several amino acids although the number of such amino acids is not particularly limited insofar as the protein has maleate isomerase activity.

Further, the present invention relates to a recombinant vector containing either of the above DNAS.

Further, the present invention relates to a transformant transformed with the recombinant vector.

Further, the present invention relates to a process for producing maleate isomerase, which comprises culturing the transformant in a medium and recovering maleate isomerase from the culture.

The addition, deletion or substitution of amino acids as described above can be effected by site-directed mutagenesis known in the art (see e.g. Nucleic Acid Research, Vol. 10, No. 20, pp. 6487-6500), and one or several amino acids are amino acids which can be added, deleted or substituted by site-directed mutagenesis.

DETAILED DESCRIPTION OF THE INVENTION

Hereinafter, the present invention is described in detail.

The microorganism used for preparing the gene of the present invention may be any microorganism producing maleate isomerase, and preferable examples are Citrobacter amalonaticus or Pseudomonas fluorescens, more preferably Citrobacter amalonaticus NSM-10 (FERM BP-6541) or Pseudomonas fluorescens NSM-4 (FERM BP-6037). The characterizing features of these 2 strains are that they produce maleate isomerase excellent in stability while the activity half-life for production is long. NSM-4 has already been applied for a patent (Japanese Patent Application No. 155833/1996).

First, genomic DNA is isolated from the microorganism. Isolation of genomic DNA can be conducted using a method known in the art, such as the SDS method, lysozyme-SDS method, or CTAB method. Preferably, the lysozyme-SDS method is used.

Then, the genomic DNA is cleaved in a usual manner with suitable restriction enzymes, and the resulting DNA is ligated to a known vector to prepare a recombinant DNA molecule. For cloning, a host microorganism is transformed with the DNA molecule. The vector includes but is not limited to pUC18. The host microorganism may be any microorganism in which the integrated gene can be maintained stably. By way of example, DH10B can be mentioned as a strain of E. coli. The method of transforming the host microorganism with the recombinant DNA molecule can be any method known in the art. For example, in vitro packaging can be used.

Then, the recombinant microorganisms obtained in this manner are screened for those containing the maleate isomerase gene. This screening can be carried out by culturing the recombinant microorganisms in a suitable medium and then measuring the enzyme activity of isomerizing maleic acid.

The recombinant DNA molecule is extracted from the recombinant microorganism thus selected. This extraction can be conducted using any conventional method for preparation of plasmid or phage DNA. A cleavage pattern of this recombinant DNA molecule by various restriction enzymes is analyzed by electrophoresis or the like.

The recombinant DNA molecule is then cleaved with various restriction enzymes, and its fragments hybridizing with a probe for detecting the maleate isomerase gene are detected. The detection probe is prepared by labeling several kinds of DNA oligomer synthesized on the basis of codons corresponding to an N-terminal amino acid sequence or a middle amino acid sequence determined by analyzing maleate isomerase in a usual manner. The DNA oligomers can be synthesized according to a method known in the art. The label used therein may be any conventional label, preferably Fluorescein-b 11.dUTP.

From the detected fragments, a suitable fragment is selected and ligated to a vector to construct a recombinant vector. It is used to transform a microorganism to give a transformant.

The procedures of preparing this transformant are not limited to those described above. For example, the genomic DNA is isolated as described above, and its fragments obtained by digestion with various restriction enzymes are analyzed by Southern hybridization with the above DNA probe, and a vector containing the fragment thus selected is used to transform a suitable host. The transformant thus obtained is cultured in a suitable medium, and the transformant having the ability to produce maleate isomerase can be selected by measuring maleate isomerase activity.

This transformant is a strain carrying the DNA of the present invention to produce maleate isomerase efficiently.

After this strain is cultured, its plasmid is extracted. An example of the microorganism is E. coli. To extract the plasmid, conventional methods can be used. The nucleotide sequence of the insert in the plasmid is analyzed, and on the basis of its sequence, the sequence of the whole maleate isomerase region in the above-described recombinant DNA molecule is determined.

The 2 DNAs of the present invention can be amplified by PCR using genomic DNA from the deposited microorganisms described above. The DNA can be amplified by PCR where an oligonucleotide consisting of about 20 nucleotides upstream from the gene obtained above and an oligonucleotide complementary to about 20 nucleotides downstream from the gene are used as primers and the genomic DNA is used as a template. In particular, the following prier sets can be used for amplifying the maleate isomerase gene of Citrobacter amalonaticus NSM-10 or Pseudomonas fluorescens NSM-4 as described above.

Citrobacter amalonaticus NSM-10 Forward side: 5'-ATGAAAAGTTTTCGAATCGGCCAAATCGTTCCCAGCTCC-3' (SEQ ID NO:5) Reverse side: 5'-TTAGTAAGCGCCCGAGAGGAGATGGCCCGG-3' (SEQ ID NO:6) Pseudomonas fluorescens NSM-4 Forward side: 5'-ATGACCAAGCCCTACCGTATCGGCCAGATCGTGC-3' (SEQ ID NO:7) Reverse side: 5'-TCAGTAGGCGCCCGACAGCAAGGCGCC-3' (SEQ ID NO:8)

EXAMPLES

Hereinafter, the present invention is described in detail with reference to the Examples, which however are not intended to limit the scope of the present invention.

Example 1

(1) Isolation and Cloning of Genomic DNA

Total DNA was isolated from a maleate isomerase-producing microorganism Pseudomonas fluorescens NMS-4. Isolation of the DNA was conducted using a modification of the method of Marmur et at. (J. Mol. Biol., 3, 208 (1961) ) used for Pseudomonas. Pseudomonas fluorescens NSM-4 was cultured overnight in LB medium, and the microorganism was recovered from the culture by centrifugation. It was lyzed with lysozyme and SDS, extracted with phenol, and precipitated with ethanol to separate the total DNA.

The total DNA thus separated was cleaved with restriction enzyme Sau3AI for a suitable time and fragments in the range of 3000 to 9000 base pairs were recovered by agarose gel electrophoresis. The recovered Sau3AI-treated fragments were cloned into a BamHI site in the known vector pUC18. E. coli DH108B was transformed in a usual manner with this vector to prepare a gene library of Pseudomonas fluorescens NSM-4. As the library, an ampicillin-resistant transformant was obtained.

(2) Selection of Transformant

The ampicillin-resistant transformant was selected by measuring its enzyme activity of isomerizing maleic acid. The ampicillin-resistant transformant was inoculated via a loop of platinum into 3 ml maleic acid medium (Table 1) containing 100 .gamma. ampicillin and cultured overnight, and the microorganism was recovered by centrifuging 1.5 ml of the culture. The recovered microorganism was suspended in 1 ml of 20% maleic acid substrate solution (Table 2) and reacted at 30.degree. C. overnight. This substrate solution contained aspartase prepared from E. coli so that fumaric acid formed by isomerization of maleic acid was converted into L-aspartic acid. After reaction, a part of the reaction solution was diluted 400-fold with distilled water and measured for its formed L-aspartic acid by HPLC analysis under the following conditions.

Column: Capsule Pack C18 UG120S-5 (Shiseido Co., Ltd.)

Temperature: 40.degree. C.

Eluent: 30 mM NH.sub.4 H.sub.2 PO.sub.4 (pH 2.5)

Flow rate: 1 ml/min

Detector: UV (210 nm)

TABLE 1______________________________________Composition of the maleic acid medium______________________________________ Maleic acid 10 g (NH.sub.4).sub.2 SO.sub.4 5 g KH.sub.2 PO.sub.4 1 g K.sub.2 HPO.sub.4 3 g MgSO.sub.4 .multidot. 7H.sub.2 O 0.5 g Yeast extract 20 g NaOH 5.5 g1 L distilled water, pH 6.2, autoclaved at 121.degree. C. for 15 minutes______________________________________ TABLE 2______________________________________Composition of the maleic acid substrate solution______________________________________maleic acid 200 g magnesium sulfate 0.5 g1 L adjusted with ammonia water to pH 8.3______________________________________ The substrate solution was prepared by adding 1 ml Triton X-100 and 2000 U aspartase from E. coli to the above solution.

When about 2000 transformants were subjected to the above-described reaction, one transformant formed L-aspartic acid. The plasmid was recovered from this transformant by the alkali-SDS method and then treated with various restriction enzymes, and the DNA fragments were analyzed by agarose gel electrophoresis. As a result, it was found that the DNA insert in the plasmid was 5.6 kb-long and was cleaved at one site cleaved with SacI or XbaI, at two sites with KpnI or NcoI, and at three sites with SmaI or SphI, but not cleaved with BamHI, HindIII or EcoRI. This plasmid was designated pMI503.

(3) Preparation of DNA Probe

The N-terminal amino acid sequence of maleate isomerase from Pseudomonas fluorescens NSM-4 was analyzed by a protein sequencer (447A, Applied Biosystems). As a result, the following amino acid sequence was obtained as the N-terminal:

Met Thr Lys Pro Tyr Arg Ile Gly Gln Ile Val Pro Ser Ser Asn Thr Thr Met Glu Thr Glu (SEQ ID NO:9)

On the basis of codons corresponding to its partial sequence, that is, Val Pro Ser Ser Asn Thr Thr Met Glu Thr Glu (SEQ ID NO:10), 12 kinds of DNA oligomer consisting of the following 32 nucleotides were synthesized by the phosphoroamidite method: 5'-GTICCIAGCTCIAACACIACIATGGAAACIGA-3' (SEQ ID NO:11). Here, I is inosine (corresponding to an arbitrary nucleotide), R is purine base A or G, and Y is pyrimidine base C or T. In CIATGG in this sequence, the presence of a NcoI restriction site was estimated. This synthetic DNA oligomer was labeled with Fluorescein-11.dUTP by terminal deoxynucleotidyl transferase and used as a detection probe for the maleate isomerase gene.

(4) Southern Hybridization

The above-described DNA fragments cleaved with the restriction enzymes and NcoI were separated by agarose gel electrophoresis, transferred to a nylon membrane and subjected to Southern hybridization with the previously prepared detection probe to examine whether fragments hybridizing therewith were present or not.

As a result, a 4-kb fragment cleaved with KpnI, a 1.4-kb fragment with SmaI, a 3-kb fragment with SphI, a 2.6-kb fragment with NcoI, and a 4.1-kb fragment with XbaI hybridized with the probe.

(5) Cloning

Out of the fragments obtained in item (4) above, the 2.6-kb fragment cleaved with NcoI was blunt-ended with DNA Blunting Kit (Takara Shuzo Co., Ltd.) and subcloned in a SmaI site in pUC18.

E. coli was transformed with the resulting plasmid and cultured, and the plasmid was extract from the E. coli by the alkali-SDS method. This plasmid was designated pPM503. The DNA nucleotide sequence of the insert in this plasmid was analyzed by the dideoxy method, and as a result, the following nucleotide sequence corresponding to the N-terminal amino acid sequence of maleate isomerase was found:

5'-ATGACCAAGCCTACCGTATCGGCCAGATCGTGCCGAGTTCGAACACCACCA-3' (SEQ ID NO:12) On the basis of this sequence, a primer for next sequencing was prepared, and analysis of 250 bases in each sequencing was repeatedly performed. By performing analysis 4 times, the sequence of the whole maleate isomerase region in plasmid pMI503 was determined. (6) Expression of the Maleate Isomerase Gene in E. coli

E. coli having the above-described pMI503 plasmid and E. coli having pUC18 plasmid were inoculated respectively via a loop of platinum into 5 ml medium shown in Table 1 and cultured at 37.degree. C. overnight under shaking. The microorganism was recovered by centrifuging 1.5 ml of the culture and then suspended in 0.5 ml maleic acid substrate solution shown in Table 2 to conduct the conversion reaction of maleic acid at 30.degree. C. By adding aspartase prepared from E. coli to the substrate solution, the formed fumaric acid was detected as L-aspartic acid. This analysis was conducted according to item (2) above. By the 16-hour reaction, E. coli DH10B-503 having pMI503 plasmid indicated 90% conversion of maleic acid, while DH108 having pUC18 plasmid not containing the insert indicated 0% conversion.

Example 2

(1) Preparation of DNA Probe

The N-terminal amino acid sequence of maleate isomerase from a maleate isomerase-producing microorganism Citrobacter amalonaticus NSM-10 was analyzed by a protein sequencer (477A, Applied Biosystems). As a result, the following amino acid sequence was obtained as the N-terminal structure:

Met Lys Ser Phe Arg Ile Gly Gln Ile Val Pro Ser Ser Asn Thr Thr Met Glu Thr Glu (SEQ ID NO:13).

On the basis of codons corresponding to its partial sequence, that is, Val Pro Ser Ser Asn Thr Thr Met Glu Thr Glu (SEQ ID NO:10), 12 kinds of DNA oligomer consisting of the following 32 nucleotides were synthesized by the phosphoroamidite method: 5'-GTICCIAGCTCIAACACIACIATGGAAACIGA-3' (SEQ ID NO:11). Here, I is inosine (corresponding to an arbitrary nucleotide), R is purine base A or G, and Y is pyrimidine base C or T. This synthetic DNA oligomer was labeled with Fluorescein-11.dUTP by terminal deoxynucleotidyl transferase and used as a detection probe for the maleate isomerase gene.

(2) Isolation of Genomic DNA

Total DNA was isolated from the maleate isomerase-producing microorganism Citrobacter amalonaticus NSM-10. Isolation of the DNA was conducted using a modification of the method of Marmur et at. (J. Mol. Biol., 3, 208 (1961)) used for Pseudomonas. Citrobacter amalonaticus NSM-10 was cultured overnight in LB medium, and the microorganism was recovered from the culture by centrifugation. It was lyzed with lysozyme and SDS, extracted with phenol, and precipitated with ethanol to separate the total DNA.

(3) Southern Hybridization

The separated total DNA was cleaved with restriction enzymes BamHI, EcoRI, SacI, KpnI, SmaI, XbaI, SalI, PstI and HindIII and the fragments were separated by agarose gel electrophoresis. The separated fragments were transferred from the agarose gel to a positively charged nylon membrane.

Blots having the DNA fragments transferred thereto were subjected to Southern hybridization with the previously prepared detection probe to examine hybridizing fragments. As a result, it was found that a restriction enzyme PstI-cleaved 1.2 kbp fragment from the total DNA of Citrobacter amalonaticus NSM-10 hybridized strongly with the probe.

(4) Cloning

The restriction enzyme PstI-cleaved 1.2 kbp fragment from the total DNA of Citrobacter amalonaticus NSM-10 was separated by electrophoresis, recovered from the agarose gel and cloned into a PstI site in the known vector pUC18. E. coli DH108B was transformed in a usual manner with this vector to prepare a gene library of Citrobacter amalonaticus NSM-10. As the library, an ampicillin-resistant transformant was obtained.

(5) Selection of the Transformant

The ampicillin-resistant transformant was selected by measuring its enzyme activity of isomerizing maleic acid. The ampicillin-resistant transformant was inoculated via a loop of platinum into 3 ml maleic acid medium (Table 1) containing 100 .gamma. ampicillin and cultured overnight, and the microorganism was recovered by centrifuging 1.5 ml of the culture. The recovered microorganism was suspended in 1 ml of 20% maleic acid substrate solution (Table 2) and reacted at 30.degree. C. overnight. This substrate solution contained aspartase prepared from E. coli so that fumaric acid formed by isomerization of maleic acid was converted into L-aspartic acid. After overnight reaction, a part of the reaction solution was diluted 400-fold with distilled water and measured for its formed L-aspartic acid by HPLC analysis. The conditions for HPLC analysis were as described in item (2) in Example 1.

After 10 transformants were reacted, 6 transformants formed L-aspartic acid. The plasmid was recovered from one of these transformants and designated pMI10a.

The DNA nucleotide sequence of the insert in this plasmid was analyzed by the dideoxy method, and as a result, the following nucleotide sequence corresponding to the N-terminal amino acid sequence of maleate isomerase was found:

5'-ATGAAAAGTTTTCGAATCGGCCAAATCGTTCCCAGCTCCAATACTACAATGGAGACAGAA-3' (SEQ ID NO:14) And this insert was found to contain the whole region of the 750-bp maleate isomerase gene coding for 250 amino acids. (6) Expression of the Maleate Isomerase Gene in E. coli

E coli having the above pMI10a plasmid and E. coli having pUC18 plasmid were inoculated respectively via a loop of platinum into 5 ml medium shown in Table 1 and cultured at 37.degree. C. overnight under shaking. The microorganism was recovered by centrifuging 1.5 ml of the culture and then suspended in 0.5 ml maleic acid substrate solution shown in Table 2 to conduct the conversion reaction of maleic acid at 30.degree. C. By adding aspartase prepared from E. coli to the substrate solution, the formed fumaric acid was detected as L-aspartic acid. This analysis was conducted according to item (5) above. By the 16-hour reaction, E. coli DH10B-10a having plasmid pMI110a indicated 95% conversion of maleic acid, while DH10B having insert-free plasmid pUC18 indicated 0% conversion.

According to the present invention, there can be obtained a gene coding for maleate isomerase, recombinant DNA containing the gene, and a transformant carrying the recombinant DNA. Maleate isomerase can be efficiently produced by use of said transformant.

__________________________________________________________________________# SEQUENCE LISTING - - - - <160> NUMBER OF SEQ ID NOS: 14 - - <210> SEQ ID NO 1 <211> LENGTH: 250 <212> TYPE: PRT <213> ORGANISM: Pseudomonas fluorescens - - <400> SEQUENCE: 1 - - Met Thr Lys Pro Tyr Arg Ile Gly Gln Ile Va - #l Pro Ser Ser AsnThr 1 5 - # 10 - # 15 - - Thr Met Glu Thr Glu Ile Pro Ala Met Leu Le - #u Ala Arg Gln Ala Ile 20 - # 25 - # 30 - - Arg Pro Glu Arg Phe Thr Phe His Ser Ser Ar - #g Met Arg Met Lys Gln 35 - # 40 - # 45 - - Val Lys Lys Glu Glu Leu Ala Ala Met Asp Gl - #y Glu Ser Asp Arg Cys 50 - # 55 - # 60 - - Ala Val Glu Leu Ser Asp Ala Lys Val Asp Va - #l Leu Gly Tyr Ala Cys 65 - #70 - #75 - #80 - - Leu Val Ala Ile Met Ala Met Gly Leu Gly Ty - #r His Arg Gln Ser Glu 85 - # 90 - # 95 - - Lys Arg Leu Gln Lys Ala Thr Ala Asp Asn As - #p Ala Leu Ala Pro Val 100 - # 105 - # 110 - - Ile Thr Ser Ala Gly Ala Leu Val Glu Ala Le - #u His Val Met Lys Ala 115 - # 120 - # 125 - - Lys Arg Ile Ala Ile Val Ala Pro Tyr Met Ly - #s Pro Leu Thr Glu Leu 130 - # 135 - # 140 - - Val Val Asn Tyr Ile Arg Glu Glu Gly Phe Gl - #u Val Gln Asp Trp Arg 145 1 - #50 1 - #55 1 -#60 - - Ala Leu Glu Ile Pro Asp Asn Leu Ala Val Al - #a Arg His Asp ThrAla 165 - # 170 - # 175 - - Asn Leu Pro Gly Ile Val Ala Gly Met Asn Le - #u Glu Gly Val Asp Val 180 - # 185 - # 190 - - Val Val Leu Ser Ala Cys Val Gln Met Gln Se - #r Leu Pro Ala Val Ala 195 - # 200 - # 205 - - Lys Val Glu Ala Gln Thr Gly Lys Pro Val Va - #l Thr Ala Ala Ile Ala 210 - # 215 - # 220 - - Thr Thr Tyr Ala Met Leu Lys Ala Leu Asp Le - #u Glu Pro Val Val Pro 225 2 - #30 2 - #35 2 -#40 - - Gly Ala Gly Ala Leu Leu Ser Gly Ala Tyr 245 - # 250 - - - - <210> SEQ ID NO 2 <211> LENGTH: 250 <212> TYPE: PRT <213> ORGANISM: Citrobacter amalonaticus - - <400> SEQUENCE: 2 - - Met Lys Ser Phe Arg Ile Gly Gln Ile Val Pr - #o Ser Ser Asn ThrThr 1 5 - # 10 - # 15 - - Met Glu Thr Glu Ile Pro Ala Met Leu Thr Se - #r Arg Tyr Ser Met Tyr 20 - # 25 - # 30 - - Pro Asp Glu Gln Phe Thr Phe His Ser Ser Ar - #g Met Arg Met Met His 35 - # 40 - # 45 - - Val Ser Pro Glu Glu Leu Lys Lys Met Asp Il - #e Asp Ser Asp Arg Cys 50 - # 55 - # 60 - - Ala Leu Glu Leu Ser Asp Ala Arg Val Asp Va - #l Met Ala Tyr Ala Cys 65 - #70 - #75 - #80 - - Leu Val Ala Ile Met Cys Gln Gly Ala Gly Ty - #r His Lys Val Ser Gln 85 - # 90 - # 95 - - Glu Arg Leu Gly Lys Ala Val Ala Ser Asn As - #n Ser Ser Ser Pro Val 100 - # 105 - # 110 - - Leu Ser Ser Ala Gly Ala Leu Ile Asp Ser Le - #u Ala Met Leu Glu Tyr 115 - # 120 - # 125 - - Lys Lys Ile Ser Ile Ile Thr Pro Tyr Met Ly - #s Pro Leu Thr Gln Gln 130 - # 135 - # 140 - - Val Ile Asp Tyr Ile Glu Ala Ala Gly Ile Gl - #u Val Val Asp Ser Ile 145 1 - #50 1 - #55 1 -#60 - - Ser Leu Glu Val Ser Asp Asn Leu Glu Val Gl - #y Arg Leu Asp ProMet 165 - # 170 - # 175 - - Asn Leu Val Gly His Ala Asp Lys Leu Lys Il - #e Gly Gln Ala Asp Gly 180 - # 185 - # 190 - - Val Val Leu Ser Cys Cys Val Gln Met Pro Se - #r Leu Pro Ala Ile His 195 - # 200 - # 205 - - Leu Val Gln Asp Arg Leu Asp Lys Pro Val Le - #u Ser Ala Ser Val Ala 210 - # 215 - # 220 - - Thr Val Tyr Gln Met Leu Lys Ala Leu Gly Le - #u Lys Ala His Val Ser 225 2 - #30 2 - #35 2 -#40 - - Asn Ala Gly His Leu Leu Ser Gly Ala Tyr 245 - # 250 - - - - <210> SEQ ID NO 3 <211> LENGTH: 750 <212> TYPE: DNA <213> ORGANISM: Pseudomonas fluorescens <220> FEATURE: <221> NAME/KEY: CDS <222> LOCATION: (1)..(750) - - <400> SEQUENCE: 3 - - atg acc aag ccc tac cgt atc ggc cag atc gt - #g ccg agt tcg aacacc 48 Met Thr Lys Pro Tyr Arg Ile Gly Gln Ile Va - #l Pro Ser Ser Asn Thr 1 5 - # 10 - # 15 - - acc atg gaa acc gag atc ccg gcg atg ctc ct - #g gcc cgc cag gcg atc 96 Thr Met Glu Thr Glu Ile Pro Ala Met Leu Le - #u Ala Arg Gln Ala Ile 20 - # 25 - # 30 - - cgc ccg gag cgc ttc acc ttc cac tcc agc cg - #c atg cgc atg aag cag 144 Arg Pro Glu Arg Phe Thr Phe His Ser Ser Ar - #g Met Arg Met Lys Gln 35 - # 40 - # 45 - - gtg aag aag gaa gaa ctg gcg gcg atg gac gg - #c gag tcc gac cgc tgc 192 Val Lys Lys Glu Glu Leu Ala Ala Met Asp Gl - #y Glu Ser Asp Arg Cys 50 - # 55 - # 60 - - gca gtg gaa ctg tca gac gcc aag gtg gac gt - #g ctc ggc tat gcc tgc 240 Ala Val Glu Leu Ser Asp Ala Lys Val Asp Va - #l Leu Gly Tyr Ala Cys 65 - #70 - #75 - #80 - - ctg gtg gcg atc atg gcc atg ggg ctg ggg ta - #c cac cgc cag tca gag 288 Leu Val Ala Ile Met Ala Met Gly Leu Gly Ty - #r His Arg Gln Ser Glu 85 - # 90 - # 95 - - aag cgg ttg caa aaa gcc act gct gac aac ga - #c gca ctg gcg ccg gtc 336 Lys Arg Leu Gln Lys Ala Thr Ala Asp Asn As - #p Ala Leu Ala Pro Val 100 - # 105 - # 110 - - atc acc agt gcc ggt gcg ctg gtg gaa gcc ct - #g cac gtg atg aag gcc 384 Ile Thr Ser Ala Gly Ala Leu Val Glu Ala Le - #u His Val Met Lys Ala 115 - # 120 - # 125 - - aag cgc atc gcc atc gtc gcg ccc tac atg aa - #g ccg ttg acc gaa ctg 432 Lys Arg Ile Ala Ile Val Ala Pro Tyr Met Ly - #s Pro Leu Thr Glu Leu 130 - # 135 - # 140 - - gtg gtc aac tac atc cgt gag gaa ggc ttc ga - #g gtg cag gac tgg cgc 480 Val Val Asn Tyr Ile Arg Glu Glu Gly Phe Gl - #u Val Gln Asp Trp Arg 145 1 - #50 1 - #55 1 -#60 - - gcg ctg gaa atc ccc gac aac ctc gcc gtg gc - #c cgt cac gac acggcc 528 Ala Leu Glu Ile Pro Asp Asn Leu Ala Val Al - #a Arg His Asp Thr Ala 165 - # 170 - # 175 - - aac ctg ccg ggc atc gtc gcc ggc atg aac ct - #t gag ggc gtc gat gtg 576 Asn Leu Pro Gly Ile Val Ala Gly Met Asn Le - #u Glu Gly Val Asp Val 180 - # 185 - # 190 - - gtg gtg ctt tca gcc tgc gtg cag atg cag tc - #g ctg ccg gca gtc gcc 624 Val Val Leu Ser Ala Cys Val Gln Met Gln Se - #r Leu Pro Ala Val Ala 195 - # 200 - # 205 - - aag gtc gag gcg caa acc ggc aaa ccg gtg gt - #c acc gct gcc atc gcc 672 Lys Val Glu Ala Gln Thr Gly Lys Pro Val Va - #l Thr Ala Ala Ile Ala 210 - # 215 - # 220 - - acc acc tac gcc atg ctc aag gcg ctg gac ct - #g gaa ccg gtg gtt ccg 720 Thr Thr Tyr Ala Met Leu Lys Ala Leu Asp Le - #u Glu Pro Val Val Pro 225 2 - #30 2 - #35 2 -#40 - - ggc gct ggc gcc ttg ctg tcg ggc gcc tac - # - # 750 Gly Ala Gly Ala Leu Leu Ser Gly Ala Tyr 245 - # 250 - - - - - - <210> SEQ ID NO 4 <211> LENGTH: 750 <212> TYPE: DNA <213> ORGANISM: Citrobacter amalonaticus <220> FEATURE: <221> NAME/KEY: CDS <222> LOCATION: (1)..(750) - - <400> SEQUENCE: 4 - - atg aaa agt ttt cga atc ggc caa atc gtt cc - #c agc tcc aat act aca 48 Met Lys Ser Phe Arg Ile Gly Gln Ile Val Pr - #o Ser Ser Asn Thr Thr 1 5 - # 10 - # 15 - - atg gag aca gaa ata ccg gcc atg ctt act tc - #t cga tac tcg atg tac 96 Met Glu Thr Glu Ile Pro Ala Met Leu Thr Se - #r Arg Tyr Ser Met Tyr 20 - # 25 - # 30 - - cct gac gaa cag ttc aca ttc cac tcc tca cg - #a atg cgc atg atg cat 144 Pro Asp Glu Gln Phe Thr Phe His Ser Ser Ar - #g Met Arg Met Met His 35 - # 40 - # 45 - - gtt agt cca gag gag ctg aag aaa atg gat at - #t gac agt gat cgt tgt 192 Val Ser Pro Glu Glu Leu Lys Lys Met Asp Il - #e Asp Ser Asp Arg Cys 50 - # 55 - # 60 - - gca ctt gag ttg agt gac gct cgc gtt gac gt - #a atg gct tac gcc tgc 240 Ala Leu Glu Leu Ser Asp Ala Arg Val Asp Va - #l Met Ala Tyr Ala Cys 65 - #70 - #75 - #80 - - ttg gta gcc ata atg tgt cag ggt gcc ggg ta - #t cac aaa gta tct cag 288 Leu Val Ala Ile Met Cys Gln Gly Ala Gly Ty - #r His Lys Val Ser Gln 85 - # 90 - # 95 - - gag cgc ttg ggg aag gca gtg gct tct aat aa - #t tca agc tct cca gtg 336 Glu Arg Leu Gly Lys Ala Val Ala Ser Asn As - #n Ser Ser Ser Pro Val 100 - # 105 - # 110 - - ctc agt tct gcg gga gcc ttg atc gat agc tt - #g gcc atg ttg gaa tac 384 Leu Ser Ser Ala Gly Ala Leu Ile Asp Ser Le - #u Ala Met Leu Glu Tyr 115 - # 120 - # 125 - - aag aag att tca atc atc acc ccc tat atg aa - #a ccg ttg act cag caa 432 Lys Lys Ile Ser Ile Ile Thr Pro Tyr Met Ly - #s Pro Leu Thr Gln Gln 130 - # 135 - # 140 - - gtg atc gac tat att gag gca gca ggt atc ga - #g gtg gta gat tct atc 480 Val Ile Asp Tyr Ile Glu Ala Ala Gly Ile Gl - #u Val Val Asp Ser Ile 145 1 - #50 1 - #55 1 -#60 - - agt ctc gaa gtg tcg gac aac ctt gaa gtt gg - #g cga ctt gat ccgatg 528 Ser Leu Glu Val Ser Asp Asn Leu Glu Val Gl - #y Arg Leu Asp Pro Met 165 - # 170 - # 175 - - aat tta gta gga cat gct gat aaa ctg aaa at - #c ggt cag gct gat ggc 576 Asn Leu Val Gly His Ala Asp Lys Leu Lys Il - #e Gly Gln Ala Asp Gly 180 - # 185 - # 190 - - gtt gtg ctt tcg tgc tgc gtt caa atg ccc tc - #t ttg ccg gcg att cat 624 Val Val Leu Ser Cys Cys Val Gln Met Pro Se - #r Leu Pro Ala Ile His 195 - # 200 - # 205 - - ctg gtc cag gat cgc cta gac aaa ccg gtt ct - #g tca gct tct gta gct 672 Leu Val Gln Asp Arg Leu Asp Lys Pro Val Le - #u Ser Ala Ser Val Ala 210 - # 215 - # 220 - - act gtc tac caa atg ttg aaa gcc ctt ggg ct - #g aag gcc cac gtc tcg 720 Thr Val Tyr Gln Met Leu Lys Ala Leu Gly Le - #u Lys Ala His Val Ser 225 2 - #30 2 - #35 2 -#40 - - aat gct ggc cat ctc ctc tcg ggc gct tac - # - # 750 Asn Ala Gly His Leu Leu Ser Gly Ala Tyr 245 - # 250 - - - - - - <210> SEQ ID NO 5 <211> LENGTH: 39 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Synthetic oligonucleotide - - <400> SEQUENCE: 5 - - atgaaaagtt ttcgaatcgg ccaaatcgtt cccagctcc - # - # 39 - - - - <210> SEQ ID NO 6 <211> LENGTH: 30 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Synthetic oligonucleotide - - <400> SEQUENCE: 6 - - ttagtaagcg cccgagagga gatggcccgg - # - # 30 - - - - <210> SEQ ID NO 7 <211> LENGTH: 34 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Synthetic oligonucleotide - - <400> SEQUENCE: 7 - - atgaccaagc cctaccgtat cggccagatc gtgc - # -# 34 - - - - <210> SEQ ID NO 8 <211> LENGTH: 27 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Synthetic oligonucleotide - - <400> SEQUENCE: 8 - - tcagtaggcg cccgacagca aggcgcc - # - # 27 - - - - <210> SEQ ID NO 9 <211> LENGTH: 21 <212> TYPE: PRT <213> ORGANISM: Pseudomonas fluorescens - - <400> SEQUENCE: 9 - - Met Thr Lys Pro Tyr Arg Ile Gly Gln Ile Va - #l Pro Ser Ser Asn Thr 1 5 - # 10 - # 15 - - Thr Met Glu Thr Glu 20 - - - - <210> SEQ ID NO 10 <211> LENGTH: 11 <212> TYPE: PRT <213> ORGANISM: Pseudomonas fluorescens - - <400> SEQUENCE: 10 - - Val Pro Ser Ser Asn Thr Thr Met Glu Thr Gl - #u 1 5 - # 10 - - - - <210> SEQ ID NO 11 <211> LENGTH: 32 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Synthetic oligonucleotide <220> FEATURE: <221> NAME/KEY: modified base <222> LOCATION: 3 <223> OTHER INFORMATION: i <220> FEATURE: <221> NAME/KEY: modified base <222> LOCATION: 6 <223> OTHER INFORMATION: i <220> FEATURE: <221> NAME/KEY: modified base <222> LOCATION: 12 <223> OTHER INFORMATION: i <220> FEATURE: <221> NAME/KEY: modified base <222> LOCATION: 18 <223> OTHER INFORMATION: i <220> FEATURE: <221> NAME/KEY: modified base <222> LOCATION: 21 <223> OTHER INFORMATION: i <220> FEATURE: <221> NAME/KEY: modified base <222> LOCATION: 30 <223> OTHER INFORMATION: i - - <400> SEQUENCE: 11 - - gtnccnagct cnaacacnac natggaaacn ga - # - # 32 - - - - <210> SEQ ID NO 12 <211> LENGTH: 51 <212> TYPE: DNA <213> ORGANISM: Pseudomonas fluorescens - - <400> SEQUENCE: 12 - - atgaccaagc ctaccgtatc ggccagatcg tgccgagttc gaacaccacc a - # 51 - - - - <210> SEQ ID NO 13 <211> LENGTH: 20 <212> TYPE: PRT <213> ORGANISM: Citrobacter amalonaticus - - <400> SEQUENCE: 13 - - Met Lys Ser Phe Arg Ile Gly Gln Ile Val Pr - #o Ser Ser Asn Thr Thr 1 5 - # 10 - # 15 - - Met Glu Thr Glu 20 - - - - <210> SEQ ID NO 14 <211> LENGTH: 60 <212> TYPE: DNA <213> ORGANISM: Citrobacter amalonaticus - - <400> SEQUENCE: 14 - - atgaaaagtt ttcgaatcgg ccaaatcgtt cccagctcca atactacaat gg -#agacagaa 60__________________________________________________________________________

Claims

1. DNA encoding a protein of (a) or (b) as follows:

(a) a protein whose amino acid sequence is represented by SEQ ID NO:1 or 2; and (b) a protein having a sequence according to SEQ ID NO:1 or 2 in which there is a single amino acid substitution, deletion or addition, wherein said protein (b) has maleate isomerase activity.

2. DNA according to claim 1 wherein the DNA is a nucleotide sequence shown in SEQ ID NO:3 or 4.

3. A recombinant vector containing the DNA described in claim 1.

4. A transformant transformed with the recombinant vector described in claim 3.

5. A process for producing maleate isomerase, which comprises culturing the transformant described in claim 4 in a medium and recovering maleate isomerase from the culture.